160 related articles for article (PubMed ID: 8938283)
1. Serine protease inhibition prevents both cellular and humoral responses to cardiopulmonary bypass.
Royston D
J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S42-9. PubMed ID: 8938283
[TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary bypass and the inflammatory response: a role for serine protease inhibitors?
Murkin JM
J Cardiothorac Vasc Anesth; 1997 Apr; 11(2 Suppl 1):19-23; discussion 24-5. PubMed ID: 9106010
[TBL] [Abstract][Full Text] [Related]
3. Review and application of serine protease inhibition in coronary artery bypass graft surgery.
Engles L
Am J Health Syst Pharm; 2005 Sep; 62(18 Suppl 4):S9-14. PubMed ID: 16227196
[TBL] [Abstract][Full Text] [Related]
4. Biochemistry of serine protease inhibitors and their mechanisms of action: a review.
Wegner J
J Extra Corpor Technol; 2003 Dec; 35(4):326-38. PubMed ID: 14979425
[TBL] [Abstract][Full Text] [Related]
5. Cardiopulmonary bypass-induced inflammation: is it important?
Hill GE
J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):21-5. PubMed ID: 9583572
[TBL] [Abstract][Full Text] [Related]
6. Aprotinin in cardiac surgery.
Sodha NR; Boodhwani M; Bianchi C; Ramlawi B; Sellke FW
Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):151-60. PubMed ID: 16509811
[TBL] [Abstract][Full Text] [Related]
7. Aprotinin improves functional outcome but not cerebral infarct size in an experimental model of stroke during cardiopulmonary bypass.
Homi HM; Sheng H; Arepally GM; Mackensen GB; Grocott HP
Anesth Analg; 2010 Jul; 111(1):38-45. PubMed ID: 20519424
[TBL] [Abstract][Full Text] [Related]
8. Effect of the neutrophil elastase inhibitor sivelestat on perioperative inflammatory response after pediatric heart surgery with cardiopulmonary bypass: a prospective randomized study.
Kohira S; Oka N; Inoue N; Itatani K; Hanayama N; Kitamura T; Fujii M; Takeda A; Oshima H; Tojo K; Yoshitake S; Miyaji K
Artif Organs; 2013 Dec; 37(12):1027-33. PubMed ID: 23834653
[TBL] [Abstract][Full Text] [Related]
9. Aprotinin and hemostasis monitoring concerns during cardiac surgery.
Swartz MF; Fink GW; Searles B
J Extra Corpor Technol; 2004 Dec; 36(4):375-83. PubMed ID: 15679283
[TBL] [Abstract][Full Text] [Related]
10. Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response?
Englberger L; Kipfer B; Berdat PA; Nydegger UE; Carrel TP
Ann Thorac Surg; 2002 Jun; 73(6):1897-904. PubMed ID: 12078788
[TBL] [Abstract][Full Text] [Related]
11. Systemic inflammatory response to coronary artery bypass graft surgery.
Hess PJ
Am J Health Syst Pharm; 2005 Sep; 62(18 Suppl 4):S6-9. PubMed ID: 16227195
[TBL] [Abstract][Full Text] [Related]
12. Aprotinin and the protease-activated receptor 1 thrombin receptor: antithrombosis, inflammation, and stroke reduction.
Day JR; Landis RC; Taylor KM
Semin Cardiothorac Vasc Anesth; 2006 Jun; 10(2):132-42. PubMed ID: 16959740
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory response to cardiopulmonary bypass.
Levy JH; Tanaka KA
Ann Thorac Surg; 2003 Feb; 75(2):S715-20. PubMed ID: 12607717
[TBL] [Abstract][Full Text] [Related]
14. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
Dietrich W
J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S50-7. PubMed ID: 8938284
[TBL] [Abstract][Full Text] [Related]
15. Genetically engineered serine protease inhibitor for hemostasis after cardiac operations.
Ohri SK; Paratt R; Becket JM; Brannan J; Hunt BJ; Taylor KM
Ann Thorac Surg; 1996 Apr; 61(4):1223-30. PubMed ID: 8607687
[TBL] [Abstract][Full Text] [Related]
16. [Serine protease inhibitors (serpins); regulators of coagulation and inflammation reactions with therapeutic potential].
Hack CE; Abbink JJ; Nuijens JH
Ned Tijdschr Geneeskd; 1990 May; 134(21):1035-9. PubMed ID: 2195358
[No Abstract] [Full Text] [Related]
17. The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation.
Chen H; Davids JA; Zheng D; Bryant M; Bot I; van Berckel TJ; Biessen E; Pepine C; Ryman K; Progulski-Fox A; Kesavalu L; Moyer R; McFadden G; Lucas A
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):99-110. PubMed ID: 23987998
[TBL] [Abstract][Full Text] [Related]
18. Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children.
Seghaye MC; Duchateau J; Grabitz RG; Jablonka K; Wenzl T; Marcus C; Messmer BJ; von Bernuth G
Ann Thorac Surg; 1996 Apr; 61(4):1205-11. PubMed ID: 8607684
[TBL] [Abstract][Full Text] [Related]
19. The inflammatory response to cardiopulmonary bypass.
Miller BE; Levy JH
J Cardiothorac Vasc Anesth; 1997 May; 11(3):355-66. PubMed ID: 9161905
[TBL] [Abstract][Full Text] [Related]
20. Aprotinin improves cerebral protection: evidence from a survival porcine model.
Anttila V; Hagino I; Iwata Y; Mettler BA; Lidov HG; Zurakowski D; Jonas RA
J Thorac Cardiovasc Surg; 2006 Oct; 132(4):948-53. PubMed ID: 17000309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
